Gossamer Bio Inc. (GOSS) NASDAQ

$7.45 -0.01 (-0.13%)

Market Cap: $575.29M

As of 05/25/22 04:00 PM EDT. Market closed.

(GOSS)

Gossamer Bio Inc. (GOSS) NASDAQ

$7.45 -0.01 (-0.13%)

Market Cap: $575.29M

As of 05/25/22 04:00 PM EDT. Market closed.

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such ... read more

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sheila Gujrathi
Full Time Employees
196
CEO Compensation (Base)
$469,601
CEO Compensation (Total)
$18.71M
URL
Address
3013 Science Park Rd, California, San Diego, 92121-1101.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sheila Gujrathi
Full Time Employees
196
CEO Compensation (Base)
$469,601
CEO Compensation (Total)
$18.71M
Address
3013 Science Park Rd, California, San Diego, 92121-1101.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$7.41
Previous Close
$7.46
Days Range
$7.17 - $7.56
52 week range
$6.28 - $14.30
Volume
491,294
Avg. Volume (30 days)
1,064,638
Market Cap
$575.29M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
77,116,705
Open
$7.41
Previous Close
$7.46
Days Range
$7.17 - $7.56
52 week range
$6.28 - $14.30
Volume
491,294
Avg. Volume (30 days)
1,064,638
Market Cap
$575.29M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
77,116,705

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GOSSAMER BIO INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Carter Laura Chief Scientific Officer May 04, 2022 Sale $7.20 1,262 9,086 89,042 May 05, 2022, 06:14 PM
Christian Waage EVP, Tech Ops and Admin Mar 23, 2022 Sale $8.91 10,722 95,587 579,008 Mar 24, 2022, 04:57 PM
Hasnain Faheem President & CEO Mar 23, 2022 Sale $8.91 19,035 169,697 143,465 Mar 24, 2022, 04:55 PM
Giraudo Bryan COO/CFO Mar 23, 2022 Sale $8.91 10,722 95,587 99,167 Mar 24, 2022, 04:53 PM
Carter Laura Chief Scientific Officer Mar 16, 2022 Sale $8.28 5,002 41,407 90,304 Mar 17, 2022, 05:03 PM
Peterson Caryn EVP, Regulatory Affairs Mar 16, 2022 Sale $8.28 6,279 51,978 66,172 Mar 17, 2022, 05:00 PM
Aranda Richard Chief Medical Officer Mar 16, 2022 Sale $8.28 6,278 51,976 211,675 Mar 17, 2022, 04:58 PM
Peterson Caryn EVP, Regulatory Affairs Oct 25, 2021 Sale $12.25 2,377 29,118 72,451 Oct 26, 2021, 05:08 PM
Carter Laura Chief Scientific Officer Oct 25, 2021 Sale $12.25 2,377 29,118 95,306 Oct 26, 2021, 05:01 PM
Aranda Richard Chief Medical Officer Oct 25, 2021 Sale $12.25 2,377 29,118 217,432 Oct 26, 2021, 04:58 PM
Salter-Cid Luisa Chief Scientific Officer Mar 23, 2021 Sale $9.48 5,491 52,052 206,065 Mar 25, 2021, 04:13 PM
Giraudo Bryan Chief Financial Officer Mar 23, 2021 Sale $9.48 5,490 52,046 109,889 Mar 25, 2021, 04:11 PM
Christian Waage EVP & General Counsel Mar 23, 2021 Sale $9.48 5,490 52,051 588,199 Mar 25, 2021, 04:09 PM
Christian Waage EVP & General Counsel Oct 14, 2020 Buy $9.53 2,500 23,818 6,954 Oct 14, 2020, 07:29 PM
Hasnain Faheem Director Oct 14, 2020 Buy $10.36 96,520 999,995 3,478,629 Oct 14, 2020, 07:28 PM
Giraudo Bryan Chief Financial Officer Oct 14, 2020 Buy $10.01 3,000 30,036 7,121 Oct 14, 2020, 07:27 PM
Giraudo Bryan Chief Financial Officer Jun 23, 2020 Buy $12.96 2,000 25,922 4,121 Jun 23, 2020, 05:01 PM
Dupont Jakob Chief Medical Officer Dec 30, 2019 Option Exercise $10.71 40,000 428,400 40,000 Dec 31, 2019, 05:00 PM
Dupont Jakob Chief Medical Officer Dec 27, 2019 Option Exercise $10.71 1,994 21,356 1,994 Dec 31, 2019, 05:00 PM
Dupont Jakob Chief Medical Officer Dec 30, 2019 Sale $15.00 40,000 600,004 0 Dec 31, 2019, 05:00 PM
Dupont Jakob Chief Medical Officer Dec 27, 2019 Sale $15.81 1,994 31,534 0 Dec 31, 2019, 05:00 PM
Christian Waage EVP & General Counsel Sep 27, 2019 Buy $16.65 1,000 16,654 4,454 Sep 27, 2019, 10:46 AM
Hasnain Faheem Director Sep 27, 2019 Buy $16.80 10,000 167,980 3,382,109 Sep 27, 2019, 10:41 AM
Gujrathi Sheila President & CEO Sep 27, 2019 Buy $16.80 10,000 167,980 4,048,242 Sep 27, 2019, 10:39 AM
Giraudo Bryan Chief Financial Officer Sep 26, 2019 Buy $16.78 1,121 18,810 2,121 Sep 26, 2019, 04:08 PM
Omega Fund V, L.P. 10% Owner Sep 20, 2019 Sale $21.96 183,607 4,032,560 6,553,416 Sep 23, 2019, 03:51 PM
Omega Fund V, L.P. 10% Owner Sep 18, 2019 Sale $21.88 45,600 997,637 6,737,023 Sep 18, 2019, 06:28 PM
Omega Fund V, L.P. 10% Owner Sep 17, 2019 Sale $21.61 23,400 505,791 6,782,623 Sep 18, 2019, 06:28 PM
Omega Fund V, L.P. 10% Owner Sep 16, 2019 Sale $21.52 13,213 284,331 6,806,023 Sep 18, 2019, 06:28 PM
Omega Fund V, L.P. 10% Owner Sep 11, 2019 Sale $21.31 80,403 1,713,629 6,819,236 Sep 12, 2019, 07:41 PM
Omega Fund V, L.P. 10% Owner Sep 10, 2019 Sale $21.00 32,373 679,865 6,899,639 Sep 12, 2019, 07:41 PM
Omega Fund V, L.P. 10% Owner Sep 05, 2019 Sale $21.60 12,704 274,434 6,940,712 Sep 09, 2019, 05:37 PM
Omega Fund V, L.P. 10% Owner Sep 06, 2019 Sale $21.51 8,700 187,103 6,932,012 Sep 09, 2019, 05:37 PM
Salter-Cid Luisa Chief Scientific Officer Aug 29, 2019 Sale $20.09 26,252 527,319 124,056 Aug 29, 2019, 06:26 PM
Salter-Cid Luisa Chief Scientific Officer Aug 28, 2019 Sale $19.65 23,748 466,724 150,308 Aug 29, 2019, 06:26 PM
Giraudo Bryan Chief Financial Officer May 30, 2019 Buy $18.70 1,000 18,700 1,000 Jun 03, 2019, 04:03 PM
Cox Russell J. Director Feb 12, 2019 Buy $16.00 7,200 115,200 7,200 Feb 12, 2019, 05:40 PM
Christian Waage EVP & General Counsel Feb 12, 2019 Buy $16.00 1,550 24,800 501,498 Feb 12, 2019, 05:36 PM
Giraudo Bryan Chief Financial Officer Feb 12, 2019 Buy $16.00 6,000 96,000 23,879 Feb 12, 2019, 05:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Carter Laura Chief Scientific Officer 05/04/2022 9,086
Christian Waage EVP, Tech Ops and Admin 03/23/2022 95,587
Hasnain Faheem President & CEO 03/23/2022 169,697
Giraudo Bryan COO/CFO 03/23/2022 95,587
Carter Laura Chief Scientific Officer 03/16/2022 41,407
Peterson Caryn EVP, Regulatory Affairs 03/16/2022 51,978
Aranda Richard Chief Medical Officer 03/16/2022 51,976
Peterson Caryn EVP, Regulatory Affairs 10/25/2021 29,118
Carter Laura Chief Scientific Officer 10/25/2021 29,118
Aranda Richard Chief Medical Officer 10/25/2021 29,118
Salter-Cid Luisa Chief Scientific Officer 03/23/2021 52,052
Giraudo Bryan Chief Financial Officer 03/23/2021 52,046
Christian Waage EVP & General Counsel 03/23/2021 52,051
Christian Waage EVP & General Counsel 10/14/2020 23,818
Hasnain Faheem Director 10/14/2020 999,995
Giraudo Bryan Chief Financial Officer 10/14/2020 30,036
Giraudo Bryan Chief Financial Officer 06/23/2020 25,922
Dupont Jakob Chief Medical Officer 12/30/2019 428,400
Dupont Jakob Chief Medical Officer 12/27/2019 21,356
Dupont Jakob Chief Medical Officer 12/30/2019 600,004
Dupont Jakob Chief Medical Officer 12/27/2019 31,534
Christian Waage EVP & General Counsel 09/27/2019 16,654
Hasnain Faheem Director 09/27/2019 167,980
Gujrathi Sheila President & CEO 09/27/2019 167,980
Giraudo Bryan Chief Financial Officer 09/26/2019 18,810
Omega Fund V, L.P. 10% Owner 09/20/2019 4,032,560
Omega Fund V, L.P. 10% Owner 09/18/2019 997,637
Omega Fund V, L.P. 10% Owner 09/17/2019 505,791
Omega Fund V, L.P. 10% Owner 09/16/2019 284,331
Omega Fund V, L.P. 10% Owner 09/11/2019 1,713,629
Omega Fund V, L.P. 10% Owner 09/10/2019 679,865
Omega Fund V, L.P. 10% Owner 09/05/2019 274,434
Omega Fund V, L.P. 10% Owner 09/06/2019 187,103
Salter-Cid Luisa Chief Scientific Officer 08/29/2019 527,319
Salter-Cid Luisa Chief Scientific Officer 08/28/2019 466,724
Giraudo Bryan Chief Financial Officer 05/30/2019 18,700
Cox Russell J. Director 02/12/2019 115,200
Christian Waage EVP & General Counsel 02/12/2019 24,800
Giraudo Bryan Chief Financial Officer 02/12/2019 96,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
06/30/2021
0.62%
2Q
12/31/2021
03/31/2021
1.01%
3Q
12/31/2021
12/31/2020
9.24%
4Q
12/31/2021
09/30/2020
11.82%
5Q
12/31/2021
06/30/2020
16.50%
6Q
12/31/2021
03/31/2020
20.93%
7Q
12/31/2021
12/31/2019
36.72%
8Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.62%
2Q
03/31/2021
1.01%
3Q
12/31/2020
9.24%
4Q
09/30/2020
11.82%
5Q
06/30/2020
16.50%
6Q
03/31/2020
20.93%
7Q
12/31/2019
36.72%
8Q
Load More